KCM
IRON icon

Kennedy Capital Management’s Disc Medicine IRON Stock Holding History

Kennedy Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.92M Buy
108,286
+98,962
+1,061% +$6.87M 0.15% 232
2025
Q4 		$740K Buy
9,324
+296
+3% +$25K 0.02% 499
2025
Q3 		$597K Buy
+9,028
New +$537K 0.01% 528

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Kennedy Capital Management's IRON Position: Q1 2026 in Review

Kennedy Capital Management increased its Disc Medicine (IRON) stake by 1,061% in Q1 2026, buying an estimated $6.87M and bringing the position to 108,286 shares worth $6.92M. The position accounts for 0.15% of the portfolio, ranked #232.

Kennedy Capital Management first reported a position in IRON in Q3 2025 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Kennedy Capital Management held 108,286 shares of Disc Medicine worth $6.92M as of Q1 2026.
  • Kennedy Capital Management bought 98,962 Disc Medicine shares in Q1 2026, an estimated $6.87M.
  • Disc Medicine made up 0.15% of Kennedy Capital Management's portfolio in Q1 2026, its #232 holding.
  • Kennedy Capital Management first reported a position in Disc Medicine in Q3 2025 and has held it in 3 quarters since.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.